EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Swedish matched cohort on the association between maternal polyendocrine metabolic ovarian syndrome and next-generation cancer risk

Romina Fornes iD, Unnur Gudnadottir iD, Sheila Orwa iD, Michael Saerens iD, Elisabet Stener-Victorin iD, Nele Brusselaers iD

JNCI Cancer Spectrum · 03.09.2026 · 10 (5)

DOI: 10.1093/jncics/pkag104 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI Cancer Spectrum, online erschienen am 05.10.2026. Verfasst von Romina Fornes und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Translational Microbiome Research (CTMR), Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Neoplasms, Metabolic Syndrome, Prenatal Exposure Delayed Effects. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Her Royal Highness crown princess Lovisa's Association for Paediatric Care, Axel Tielman Memorial Foundation, Her Royal Highness crown princess Lovisa’s Association for Paediatric Care.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Polyendocrine metabolic ovarian syndrome (PMOS) is an endocrine and metabolic disorder associated with adverse perinatal and long-term health outcomes, yet its impact on cancer risk in children remains unclear.

Methods

We conducted a nationwide, register-based matched cohort study in Sweden, including children of primiparous women with (N = 22 955) and without PMOS (N = 103 613) born between 1973 and 2018. Children were followed from birth until cancer diagnosis, death, or December 2018. Conditional Cox proportional hazards models estimated the adjusted hazard ratio (aHR) with 95% CI, incorporating time-varying effects when the proportional hazards assumption was violated.

Results

During follow-up, 666 children were diagnosed with cancer. Compared with children born to women without PMOS, overall cancer risk among children of women with PMOS differed by sex and over time. Among sons, higher hazards at 1 year were observed (aHR = 4.17; 95% CI = 2.51 to 6.93), decreasing by 10 years (aHR = 1.53; 95% CI = 1.08 to 2.18). In daughters, hazard ratios did not indicate a change in overall cancer risk compared to reference. When both sexes were combined, risk of lymphatic and hematopoietic malignancies was higher (aHR = 2.43; 95% CI = 1.36 to 4.33). Competing risks of death did not materially alter the associations.

Conclusions

Overall cancer risk among children born to women with PMOS differed by sex and over time, with higher risks in sons during early life. These findings suggest that maternal PMOS may be associated with differential cancer susceptibility across the life course.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsMetabolic SyndromePrenatal Exposure Delayed EffectsHumansFemaleSwedenProportional Hazards ModelsRegistriesPregnancyCohort StudiesMaleAdultRisk FactorsChildSex FactorsHematologic NeoplasmsChild, Preschool

Autor:innen und Institutionen

  • Centre for Translational Microbiome Research (CTMR), Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Global Health Institute, Department of Family Medicine and Population Health, University of Antwerp, Antwerp, Belgium.
  • Department of Medical Oncology, Ghent University Hospital, Ghent, Belgium.
  • Cancer Research Institute Ghent, Ghent University, Ghent, Belgium.
  • Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.

ORCID-Profile: Romina Fornes, Unnur Gudnadottir, Sheila Orwa, Michael Saerens, Elisabet Stener-Victorin, Nele Brusselaers

Förderung

  • Her Royal Highness crown princess Lovisa's Association for Paediatric Care
  • Axel Tielman Memorial Foundation
  • Her Royal Highness crown princess Lovisa’s Association for Paediatric Care

Zitieren

APA

Fornes, R., Gudnadottir, U., Orwa, S., Saerens, M., Stener-Victorin, E., & Brusselaers, N. (2026). Swedish matched cohort on the association between maternal polyendocrine metabolic ovarian syndrome and next-generation cancer risk. JNCI Cancer Spectrum, 10(5). https://doi.org/10.1093/jncics/pkag104

Vancouver

Fornes R, Gudnadottir U, Orwa S, Saerens M, Stener-Victorin E, Brusselaers N. Swedish matched cohort on the association between maternal polyendocrine metabolic ovarian syndrome and next-generation cancer risk. JNCI Cancer Spectrum. 2026;10(5). doi:10.1093/jncics/pkag104

BibTeX
@article{Fornes2026,
  author = {Fornes, Romina and Gudnadottir, Unnur and Orwa, Sheila and Saerens, Michael and Stener-Victorin, Elisabet and Brusselaers, Nele},
  title = {Swedish matched cohort on the association between maternal polyendocrine metabolic ovarian syndrome and next-generation cancer risk},
  journal = {JNCI Cancer Spectrum},
  year = {2026},
  volume = {10},
  number = {5},
  doi = {10.1093/jncics/pkag104}
}
Kostenlos starten →